Dr Alison Birtle (Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK), Dr Ignacio Durán (Hospital Universitario Virgen del Rocío, Sevilla, Spain), Dr Friederike Schlürmann (Centre Hospitalier Universitaire de Brest, Brest, France), Dr Yohann Loriot (Gustave Roussy, Paris, France) and Dr Peter Goebell (University Comprehensive Cancer Center (UCC) Erlangen, Erlangen, Germany) discuss the 'Latest developments in the treatment of bladder cancer' in this ecancer online webinar.

After introducing the topic of the discussion, Dr Birtle and Dr Durán ask the panel what data they found surprising at ASCO and ESMO 2023.

The panel then discusses the management of patients with bladder cancer and current available treatments. They explain how any new clinical data fits into the wider landscape of developments presented in the 2nd half of 2023 and how they impact our understanding of best clinical practice.

The panel also covers the evolving landscape in the treatment of bladder cancer and identify how to effectively integrate any developments into the management of patients with bladder cancer.